Entity Type
Company
Filer Snapshot
Apimeds Pharmaceuticals US, Inc. SEC EDGAR Filings
SEC filings, ownership reports, and insider transactions for CIK 0001894525.
Total Filings
112
Latest Filing
22 Apr 2026
Industry
Pharmaceutical Preparations
Save this filer page for the next filing cycle
Keep this page in your research queue, then return to compare new filings with prior context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Best next steps
Start with the latest filings table, then open the strongest context page for this filer.
- Use the filings table to verify the newest submission, form type, and report period.
- Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC filing 8-K
View Source Filing
8-K filed on 22 Apr 2026 for CIK 0001894525.
- Symbol
- APUS on NYSE
- Business address
- 100 Matawan Rd, Suite 325, Matawan, NJ, 07747
- State of incorporation
- DE
- Fiscal year end
- 31 December
Quick Takeaways
- Apimeds Pharmaceuticals US, Inc. is an SEC filer tracked under CIK 0001894525.
- 112 filings are listed on this profile.
- Common form coverage includes 8-K, 425, 8-K/A and more.
What Changed
- Latest filing: 8-K filed on 22 Apr 2026.
- Report period: 17 Apr 2026.
Why This Matters
- You can quote filing dates and form types directly from the SEC record on this page.
- Use this profile before deeper ownership or insider analysis to confirm filing history context.
Source Evidence
Source: SEC filing 8-K
View Source Filing
8-K filed on 22 Apr 2026 for CIK 0001894525.
Return Loop
Why revisit this filer page
A newly filed 8-K can change the filing history, ownership context, or next research path for Apimeds Pharmaceuticals US, Inc..
- Latest source-backed update
- 8-K filed 22 Apr 2026
- Why come back
- Revisit after a new SEC filing appears to compare the updated record with prior filings.
- Latest filing on record: 8-K filed 22 Apr 2026.
- Save this filer if you want a stable place to return after the next filing cycle.
- Open the latest filing table or ownership context to verify what changed.
Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.
Latest update
What changed recently for Apimeds Pharmaceuticals US, Inc.
Latest financial period: Q3 2025. Open the source-backed page to inspect the fresh filing or facts context.
Update date
12 Nov 2025
Page type
Company facts
Latest period
Q3 2025
SEC-backed company facts were refreshed from filings filed on 12 Nov 2025.
Benchmark Context
Benchmark context for this company
Apimeds Pharmaceuticals US, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q3 2025. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 12 Nov 2025.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
Filer Overview
Apimeds Pharmaceuticals US, Inc. has filed 112 SEC EDGAR filings since 29 Jan 2024. Common forms include 8-K, 425, 8-K/A, NT 10-K and more.
Latest Filings
Recent SEC filings for Apimeds Pharmaceuticals US, Inc. with direct links to document and filing folders.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | FORM 8-K | 22 Apr 2026 | 17 Apr 2026 | 001-42545 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 16 Apr 2026 | 15 Apr 2026 | 001-42545 |
| 425 | Open 425 document | View SEC filing for 425 | AMENDMENT NO. 1 TO FORM 8-K | 09 Apr 2026 | 001-42545 | |
| 8-K/A | Open 8-K/A document | Open XBRL data | View SEC filing for 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 09 Apr 2026 | 20 Mar 2026 | 001-42545 |
| NT 10-K | Open NT 10-K document | View SEC filing for NT 10-K | NOTIFICATION OF LATE FILING | 31 Mar 2026 | 31 Dec 2025 | 001-42545 |
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 30 Mar 2026 | 005-95043 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 26 Mar 2026 | 20 Mar 2026 | 001-42545 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 25 Mar 2026 | 20 Mar 2026 | 001-42545 |
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 20 Mar 2026 | 005-95043 | ||
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 16 Mar 2026 | 16 Mar 2026 | 001-42545 |
| DEFM14C | Open DEFM14C document | View SEC filing for DEFM14C | INFORMATION STATEMENT | 27 Feb 2026 | 001-42545 | |
| 425 | Open 425 document | View SEC filing for 425 | AMENDMENT NO. 2 TO FORM 8-K | 17 Feb 2026 | 001-42545 | |
| 8-K/A | Open 8-K/A document | Open XBRL data | View SEC filing for 8-K/A | AMENDMENT NO. 2 TO FORM 8-K | 17 Feb 2026 | 01 Dec 2025 | 001-42545 |
| SCHEDULE 13G | Open SCHEDULE 13G document | View SEC filing for SCHEDULE 13G | 11 Feb 2026 | 005-95043 | ||
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 26 Jan 2026 | 005-95043 | ||
| PREM14C | Open PREM14C document | Open XBRL data | View SEC filing for PREM14C | INFORMATION STATEMENT | 16 Jan 2026 | 16 Jan 2026 | 001-42545 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 02 Jan 2026 | 30 Dec 2025 | 001-42545 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 10 Dec 2025 | 05 Dec 2025 | 001-42545 |
| 8-K/A | Open 8-K/A document | Open XBRL data | View SEC filing for 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 10 Dec 2025 | 01 Dec 2025 | 001-42545 |
| 425 | Open 425 document | View SEC filing for 425 | CURRENT REPORT | 02 Dec 2025 | 001-42545 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 02 Dec 2025 | 01 Dec 2025 | 001-42545 |
| 4/A | Open 4/A document | View SEC filing for 4/A | PRIMARY DOCUMENT | 21 Nov 2025 | 12 May 2024 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 18 Nov 2025 | 13 Nov 2025 | 001-42545 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2025 | 11 Nov 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2025 | 11 Nov 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2025 | 11 Nov 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2025 | 11 Nov 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 13 Nov 2025 | 11 Nov 2025 | |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | QUARTERLY REPORT | 12 Nov 2025 | 30 Sep 2025 | 001-42545 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 24 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 21 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Oct 2025 | 15 Oct 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 17 Oct 2025 | 15 Oct 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 16 Oct 2025 | 15 Oct 2025 | 001-42545 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | QUARTERLY REPORT | 19 Aug 2025 | 30 Jun 2025 | 001-42545 |
| NT 10-Q | Open NT 10-Q document | View SEC filing for NT 10-Q | NOTIFICATION OF LATE FILING | 14 Aug 2025 | 30 Jun 2025 | 001-42545 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 16 Jul 2025 | 15 Jul 2025 | 001-42545 |
| 4/A | Open 4/A document | View SEC filing for 4/A | PRIMARY DOCUMENT | 11 Jun 2025 | 12 May 2025 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | PRIMARY DOCUMENT | 11 Jun 2025 | 04 Mar 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 05 Jun 2025 | 30 May 2025 | 001-42545 |
| S-8 | Open S-8 document | View SEC filing for S-8 | REGISTRATION STATEMENT | 23 May 2025 | 333-287564 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 20 May 2025 | 16 May 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 20 May 2025 | 16 May 2025 | 001-42545 |
| 10-Q | Open 10-Q document | Open XBRL data | View SEC filing for 10-Q | QUARTERLY REPORT | 20 May 2025 | 31 Mar 2025 | 001-42545 |
| SCHEDULE 13D | Open SCHEDULE 13D document | Open XBRL data | View SEC filing for SCHEDULE 13D | 19 May 2025 | 005-95043 | ||
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 15 May 2025 | 13 May 2025 | |
| NT 10-Q | Open NT 10-Q document | View SEC filing for NT 10-Q | NOTIFICATION OF LATE FILING | 15 May 2025 | 31 Mar 2025 | 001-42545 |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 May 2025 | 12 May 2025 | |
| 4 | Open 4 document | View SEC filing for 4 | PRIMARY DOCUMENT | 14 May 2025 | 12 May 2025 | |
| 3/A | Open 3/A document | View SEC filing for 3/A | PRIMARY DOCUMENT | 14 May 2025 | 04 Mar 2025 | |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 12 May 2025 | 08 May 2025 | 001-42545 |
| 424B4 | Open 424B4 document | View SEC filing for 424B4 | PROSPECTUS | 09 May 2025 | 333-282324 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| 3 | Open 3 document | View SEC filing for 3 | PRIMARY DOCUMENT | 08 May 2025 | 04 Mar 2025 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 05 May 2025 | 333-282324 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 05 May 2025 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 05 May 2025 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 05 May 2025 | 001-42545 | ||
| POS AM | Open POS AM document | Open XBRL data | View SEC filing for POS AM | POST-EFFECTIVE AMENDMENT | 02 May 2025 | 333-282324 | |
| 10-K/A | Open 10-K/A document | Open XBRL data | View SEC filing for 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 02 May 2025 | 31 Dec 2024 | 001-42545 |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 01 May 2025 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 01 May 2025 | |||
| POS AM | Open POS AM document | Open XBRL data | View SEC filing for POS AM | POST-EFFECTIVE AMENDMENT | 01 May 2025 | 333-282324 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 01 May 2025 | 001-42545 | ||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 30 Apr 2025 | 333-282324 | ||
| POS AM | Open POS AM document | Open XBRL data | View SEC filing for POS AM | POST-EFFECTIVE AMENDMENT | 17 Apr 2025 | 333-282324 | |
| 10-K | Open 10-K document | Open XBRL data | View SEC filing for 10-K | ANNUAL REPORT | 15 Apr 2025 | 31 Dec 2024 | 001-42545 |
| 8-K | Open 8-K document | Open XBRL data | View SEC filing for 8-K | CURRENT REPORT | 15 Apr 2025 | 11 Apr 2025 | 001-42545 |
| NT 10-K | Open NT 10-K document | View SEC filing for NT 10-K | NOTIFICATION OF LATE FILING | 31 Mar 2025 | 31 Dec 2024 | 001-42545 |
| CERT | Open CERT document | View SEC filing for CERT | NYSE AMERICAN CERTIFICATION | 04 Mar 2025 | 001-42545 | |
| 8-A12B | Open 8-A12B document | View SEC filing for 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | 03 Mar 2025 | 001-42545 | |
| EFFECT | Open EFFECT document | View SEC filing for EFFECT | 11 Feb 2025 | 333-282324 | ||
| FWP | Open FWP document | View SEC filing for FWP | FREE WRITING PROSPECTUS | 10 Feb 2025 | 333-282324 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 10 Feb 2025 | |||
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 10 Feb 2025 | 333-282324 | |
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 07 Feb 2025 | 377-07074 | ||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 07 Feb 2025 | |||
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 07 Feb 2025 | |||
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 06 Feb 2025 | 333-282324 | |
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 29 Jan 2025 | 333-282324 | |
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 10 Jan 2025 | 333-282324 | |
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 20 Dec 2024 | 333-282324 | |
| CORRESP | Open CORRESP document | View SEC filing for CORRESP | 19 Dec 2024 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 16 Dec 2024 | 377-07074 | ||
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 09 Dec 2024 | 333-282324 | |
| S-1/A | Open S-1/A document | View SEC filing for S-1/A | REGISTRATION STATEMENT | 08 Nov 2024 | 333-282324 | |
| S-1 | Open S-1 document | View SEC filing for S-1 | REGISTRATION STATEMENT | 25 Sep 2024 | 333-282324 | |
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 05 Aug 2024 | 377-07074 | ||
| DRSLTR | Open DRSLTR document | View SEC filing for DRSLTR | 02 Aug 2024 | |||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 17 Jun 2024 | 377-07074 | ||
| DRSLTR | Open DRSLTR document | View SEC filing for DRSLTR | 14 Jun 2024 | |||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 23 May 2024 | 377-07074 | ||
| DRSLTR | Open DRSLTR document | View SEC filing for DRSLTR | 13 May 2024 | |||
| DRS/A | Open DRS/A document | View SEC filing for DRS/A | 13 May 2024 | 377-07074 | ||
| UPLOAD | Open UPLOAD document | View SEC filing for UPLOAD | 26 Feb 2024 | 377-07074 | ||
| DRS | Open DRS document | View SEC filing for DRS | 29 Jan 2024 | 377-07074 |
About this filer
Apimeds Pharmaceuticals US, Inc. files with the SEC under CIK 0001894525. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.
FAQ
- What is a CIK?
- A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
- Why are some filings missing?
- New filings appear as the SEC updates EDGAR, and older records can vary by availability.
- How often is this page updated?
- Updates follow new EDGAR submissions and periodic data refreshes.